While it is out of the scope of this review to outline all the complex interconnections between ferroptosis, cancer and drug resistance, we want to point out three promising drug targets at this interface, namely NRF2, SLC7A11, and GPX4, and refer to comprehensive review articles in this field.21, 42, 48, 70, 132. Here, GPX4 is linked to cancer.